<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Clinical development of antibody-based receptor tyrosine kinase inhibitors for cancer therapy</dc:title>
  <dc:creator>ZHENPING ZHU</dc:creator>
  <dc:creator>HICKLIN, Daniel J</dc:creator>
  <dc:creator>BOHLEN, Peter</dc:creator>
  <dc:creator>WAKSAL, Harlan</dc:creator>
  <dc:creator>WITTE, Larry</dc:creator>
  <dc:contributor>Pandalai, S. G</dc:contributor>
  <dc:relation>Recent research developments in quantum electronics, pp. 369-384</dc:relation>
  <dc:date>2001</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Book Chapter</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Transworld research network</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>16 p. ; 141 ref</dc:format>
  <dc:subject xml:lang="fr">Cytokine</dc:subject>
  <dc:subject xml:lang="fr">Enzyme</dc:subject>
  <dc:subject xml:lang="fr">Facteur croissance</dc:subject>
  <dc:subject xml:lang="fr">Polypeptide</dc:subject>
  <dc:subject xml:lang="fr">Transferases</dc:subject>
  <dc:subject xml:lang="fr">Anticancéreux</dc:subject>
  <dc:subject xml:lang="fr">Anticorps monoclonal</dc:subject>
  <dc:subject xml:lang="fr">Article synthèse</dc:subject>
  <dc:subject xml:lang="fr">Facteur croissance endothélium vasculaire</dc:subject>
  <dc:subject xml:lang="fr">Facteur croissance épiderme</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Immunothérapie</dc:subject>
  <dc:subject xml:lang="fr">Protein-tyrosine kinase</dc:subject>
  <dc:subject xml:lang="fr">Récepteur biologique</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Tumeur maligne</dc:subject>
  <dc:subject xml:lang="en">Cytokine</dc:subject>
  <dc:subject xml:lang="en">Enzyme</dc:subject>
  <dc:subject xml:lang="en">Growth factor</dc:subject>
  <dc:subject xml:lang="en">Polypeptide</dc:subject>
  <dc:subject xml:lang="en">Transferases</dc:subject>
  <dc:subject xml:lang="en">Antineoplastic agent</dc:subject>
  <dc:subject xml:lang="en">Monoclonal antibody</dc:subject>
  <dc:subject xml:lang="en">Review</dc:subject>
  <dc:subject xml:lang="en">Vascular endothelium growth factor</dc:subject>
  <dc:subject xml:lang="en">Epidermal growth factor</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Immunotherapy</dc:subject>
  <dc:subject xml:lang="en">Protein-tyrosine kinase</dc:subject>
  <dc:subject xml:lang="en">Biological receptor</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Malignant tumor</dc:subject>
  <dc:subject xml:lang="es">Citoquina</dc:subject>
  <dc:subject xml:lang="es">Enzima</dc:subject>
  <dc:subject xml:lang="es">Factor crecimiento</dc:subject>
  <dc:subject xml:lang="es">Polipéptido</dc:subject>
  <dc:subject xml:lang="es">Transferases</dc:subject>
  <dc:subject xml:lang="es">Anticanceroso</dc:subject>
  <dc:subject xml:lang="es">Anticuerpo monoclonal</dc:subject>
  <dc:subject xml:lang="es">Artículo síntesis</dc:subject>
  <dc:subject xml:lang="es">Factor crecimiento endotelio vascular</dc:subject>
  <dc:subject xml:lang="es">Factor crecimiento epidermi</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Inmunoterapia</dc:subject>
  <dc:subject xml:lang="es">Protein-tyrosine kinase</dc:subject>
  <dc:subject xml:lang="es">Receptor biológico</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject xml:lang="es">Tumor maligno</dc:subject>
  <dc:subject>002B02R03: Immunothérapie / Immunotherapy</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 14558776</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>